Westminster, CA – June 13, 2019 – BioLargo, Inc.
(OTCQB:BLGO), developer of sustainable products and a full-service
environmental engineering company, today announced that a third-party study (download it HERE) had
concluded its industrial odor control product CupriDyne® Clean eliminates
“terpenes”, which cause the odors in cannabis grow and production facilities. Conducted
by Southern Air Systems Corp (SAS) out of Knoxville Tennessee, the study analyzed
the two key odor-causing terpenes: myrcene and limonene. In business since
1989, SAS personnel have more than 60 years of combined experience exclusively
providing air quality services to the power, petroleum and chemical industries.
The study concludes,
“After treatment with CupriDyne Clean, no trace of
terpenes was detected in the air samples.”
BioLargo President & CEO Dennis P. Calvert commented, “This
is a momentous day for CupriDyne Clean. Although field trials had already
demonstrated that it was effective against odors caused by cannabis
cultivation, this data set represents crucial scientific validation that should
accelerate adoption of the product by cannabis and hemp industry operators.
Many of the major players in the cannabis industry are scientifically minded,
and third party validated data sets like this are crucial to earning their
business.”
Terpenes are highly odorous volatile organic compounds (VOCs)
produced in cannabis cultivation and processing, and are known hazardous air
pollutants when present at high concentration. In many jurisdictions Cannabis growers
are required by regulators to enact air quality control measures to mitigate odor-causing
terpenes at their operations (such as in Los
Angeles County). The predominant solution currently used by the industry is
carbon-based filters, which are expensive to purchase, install, and replace,
and are widely known to be inadequate for handling the high volume of terpenes
produced by industrial cannabis cultivation facilities. In order to comply with
regulations and maintain good relations with neighbors, growers and processors
in the booming cannabis market are seeking better active solutions to managing
terpenes.
Joe Provenzano, President of BioLargo’s wholly owned
subsidiary Odor-No-More, Inc. commented, “CupriDyne Clean is sold by a
distributor to the industry under the Cannabusters brand (www.thecannabusters.com). These results
increase our confidence in the product’s capacity to revolutionize odor
control in the cannabis industry. Unlike many competitors, our product doesn’t
just mask the odor-causing VOCs, it breaks them down through oxidation, meaning
it is better at improving air quality. Our product is environmentally friendly,
non-toxic, and a not a pesticide, making it an attractive solution for the cannabis
industry.”
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and
environmental engineering company driven by a mission to "make life
better" by delivering robust, sustainable solutions for a broad range of
industries and applications, with a focus on clean water, clean air, and
advanced wound care. We develop and commercialize disruptive technologies by
providing the capital, support, and expertise to expedite them from
"cradle" to "maturity" (www.biolargo.com).
Our engineering division features experienced professional engineers dedicated
to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne
Clean Industrial Odor Eliminator (www.cupridyne.com),
which eliminates the odor-causing compounds and VOCs rather than masking them,
and is now winning over leading companies in the solid waste handling and
wastewater industries and other industries that contend with malodors and VOCs.
Our subsidiary BioLargo Water (www.biolargowater.ca)
develops the Advanced Oxidation System "AOS," a disruptive industrial
water treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective
and gentle solutions for chronic wounds to promote infection control and
regenerative tissue therapy.
Contact Information
Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863
Safe Harbor Act
This press release includes “forward-looking statements”
within the meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Actual results may differ from
expectations, estimates and projections and, consequently, you should not rely
on these forward-looking statements as predictions of future events. Words such
as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,”
“intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,”
“potential,” “continue,” and similar expressions are intended to identify such
forward-looking statements. These forward-looking statements involve
significant risks and uncertainties that could cause the actual results to
differ materially from the expected results.